🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Feasibility and Clinical Utility of Paired Non-Invasive Hemodynamic and Tissue Oximetry Monitoring to Detect Limb Ischemia in Lithotomy-Positioned Surgeries

Recruitingn/aAges any - anyFemaleThe University of Texas Health Science Center, Ho…
NCT07387653 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The LIMB Study is a prospective, observational pilot study evaluating the feasibility of combined non-invasive hemodynamic and lower-limb tissue oximetry monitoring during prolonged minimally invasive pelvic surgeries performed in lithotomy position. Thirty patients will undergo continuous intraoperative monitoring, with the primary outcome being the frequency and duration of tissue oxygen desaturation events and secondary outcomes examining correlations with postoperative limb pain, sensation, and motor function. The study is non-interventional, poses minimal risk, and aims to generate preliminary data to inform future strategies for early detection and prevention of limb ischemia and well-leg compartment syndrome

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Adult patients 2. Undergoing minimally invasive pelvic surgery (such as hysterectomy, myomectomy, or endometriosis surgery) 3. Surgery performed in lithotomy position 4. Expected surgical duration \> 2 hours as determined by the primary surgeon Exclusion Criteria: 1. Pregnant patients 2. Procedures expected to last \< 2 hours 3. Open surgical approaches 4. Minor procedures 5. Known allergy or sensitivity to adhesives used for monitoring sensors 6. Vulnerable populations (incarcerated, elderly or pregnant)
💊

What it tests

  • Lower-Extremity Perfusion Monitoring
📍

Where

2 sites
Memorial Hermann Medical Center
Houston, United States
Memorial Hermann Hospital
Houston, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy